Insulina glargina lantus pdf

Mild hypoglycemia may be treated by ingestion of oral glucose. Insulin glargine is a longacting, recombinant human insulin analog that is given once daily as a basal source of insulin in patients with type 1 or type 2 diabetes mellitus. Lantus insulin glargin 100eml basinsulin med effekt i upp till 24 timmar. If lantus is diluted or mixed, the solution may become cloudy, and the pharmacokinetic pharmacodynamic profile e. If using a new vial, pull off the plastic protective cap, but do not remove the rubber stopper 2. The availability of an insulin preparation that would provide basal insulin requirements has long. A service of the national library of medicine, national institutes of health. Lantus vial insulin glargine injection 100 unitsml supplies needed lantus vial syringe with needle sharps container alcohol swabs where to inject. Recovery from hypoglycemia may be delayed due to the prolonged effectofsubcutinsulinglargine. Resources for your patients lantus insulin glargine. Lantus solostar 100 unidadesml solucion inyectable en. Lantus vial insulin glargine injection 100 unitsml 2 1. Tresiba to lantus conversion chart slidell little theatre concert nellie drive, slidell tresiba flextouch insulina tresiba vs lantus tresiba penfill bula.

Har finner du information om lantus egenskaper och. Improved glycaemic control with reduced hypoglycaemic episodes and without weight gain using longterm modern premixed insulins in type 2 diabetes. Ficha tecnica lantus 100 unidadesml solucion inyectable en. Important safety information for lantus insulin glargine injection solostar lantus solostar is a disposable singlepatientuse prefilled insulin pen. Lantus ar ett langverkande basinsulin for patienter med diabetes typ 1 och diabetes typ 2. Highlights of prescribing information hyperglycemia or. Lantus deve ser administrado uma vez por dia a qualquer hora, mas a mesma hora todos os dias. Stomach, except for the 2inches around the belly button 2. Lantus dient eenmaal daags op elk tijdstip maar steeds op. O regime posologico dose e hora da dose deve ser ajustado individualmente. Lantus must not be mixed with any other insulin or diluted with any other solution. Lantus insulina glargina sanofiaventis farmaceutica ltda. Lantus bevat insuline glargine, een insulineanaloog, en heeft een verlengde werkingsduur.

Pode ser administrada a qualquer hora do dia, entretanto, no mesmo horario todos os dias. Lantus is a longacting human insulin analog indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus. Insulina glargina e uma nova insulina humana recombinante analoga, equipotente a insulina humana. Ficha tecnica lantus 100 unidadesml solucion inyectable. Indicaciones, posologia y efectos secundarios ccm salud.

Please talk to your healthcare provider about proper injection technique and follow instructions in the instruction leaflet that accompanies the pen. Toujeo comparado a lantus, insulina glargina doctablet. Id like to take a few minutes to tell you what you need to know about starting lantus insulin glargine injection 100 unitsml using the solostar pen. Lantus al tomar su medicamento conozca su insulina. Prospecto lantus solostar 100 unidadesml solucion inyectable. Hold the syringe with the needle pointing up in the air and. One dose of lantus at the same time each day works all day and all night. Youve taken an important step by adding lantus to your diabetes treatment plan. Lantus behover bara tas en gang om dagen, vid en tidpunkt som passar patienten sjalv, dock samma tid varje dag. Lantus esta contraindicada em pacientes com alergia a insulina glargina ou a qualquer um dos componentes da formula. Lantus insulin glargin 100eml basinsulin effekt 24 timmar. Lantus apresenta um efeito mais prolongado quando comparado com a insulina humana. Lantus vial insulin glargine injection 100 unitsml. The new longacting insulin analogue, insulin glargine lantus, aventis pharma was approved for use in patients with type 1 and type 2 diabetes mellitus by the us food and drug administration in april, 2000, and by the european agency for the evaluation of medicinal products in june, 2000.